Stock Evaluator: iSpecimen Inc. (ISPC)

iSpecimen Inc. ISPC

$1.89 0.06 3.28%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 35,534
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Technology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company’s marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

Commentary & Analysis


Financial Summary

Share Statistics ISPC Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2.7 $179.6 2%
Shares Out (Mil) 0.3 47.9 2%
Institutional Ownership 100.0% 78.6% 99%
Float (Mil) 1.4 40.1 4%
Beta 1.75 1.22 88%
Avg Daily Volume (000s) 44 205 27%
Price Change
(52-week)
(96.3%) 41.0% 2%
Growth ISPC Industry
Median
Percentile
(All Stocks)
Sales (5yr) (25.4%) 13.7% 2%
Net Income (5yr) (17.4%) (1.0%) 23%
EPS (5yr) na 15.5% na
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) na (15.5%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials ISPC Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $1 $192 2%
Net Income (TTM) (Mil) ($11) ($9) 28%
EPS (TTM) ($59.737) ($0.500) 1%
Operating Cash Flow (TTM) (Mil) ($7) $8 23%
Net Cash Flow (TTM) (Mil) na ($3) na
Long-Term Debt (Q1) (Mil) $0 $14 12%
Enterprise Value (Q1) (Mil) $2 $215 4%
Valuation ISPC Industry
Median
Percentile
(All Stocks)
P/B 1.72 1.22 45%
P/E na 36.1 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 2.0 na
Ratios ISPC Industry
Median
Percentile
(All Stocks)
Gross Margin (29.6%) 61.6% 3%
Net Margin na (29.3%) na
ROA (165.1%) (21.9%) 3%
ROE (894.6%) (1.4%) 0%
Liabilities to Assets 87.7% 33.3% 82%
F-Score 2 4 7%

iSpecimen Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors